{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T08:40:29Z","timestamp":1648888829714},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11894-019-0717-2","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T05:04:56Z","timestamp":1566536696000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Microbial Profiles of Cirrhosis in the Human Small Intestine"],"prefix":"10.1007","volume":"21","author":[{"given":"Tien S.","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehnaz K.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"717_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.20632","volume":"41","author":"R Wiest","year":"2005","unstructured":"Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology. 2005;41:422\u201333.","journal-title":"Hepatology"},{"key":"717_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","volume":"68","author":"H Chu","year":"2019","unstructured":"Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68:359\u201370.","journal-title":"Gut"},{"key":"717_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","volume":"551","author":"S Shalapour","year":"2017","unstructured":"Shalapour S, Lin X-J, Bastian IN, Brain J, Burt AD, Aksenov AA, et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature. 2017;551:340\u20135.","journal-title":"Nature"},{"key":"717_CR4","doi-asserted-by":"publisher","first-page":"s58","DOI":"10.5604\/01.3001.0010.5498","volume":"16","author":"V Cruz-Ram\u00f3n","year":"2017","unstructured":"Cruz-Ram\u00f3n V, Chinchilla-L\u00f3pez P, Ram\u00edrez-P\u00e9rez O, M\u00e9ndez-S\u00e1nchez N. Bile acids in nonalcoholic fatty liver disease: new concepts and therapeutic advances. Ann Hepatol. 2017;16:s58\u201367.","journal-title":"Ann Hepatol"},{"key":"717_CR5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1099\/jmm.0.45935-0","volume":"54","author":"H Hayashi","year":"2005","unstructured":"Hayashi H, Takahashi R, Nishi T, Sakamoto M, Benno Y. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol. 2005;54:1093\u2013101.","journal-title":"J Med Microbiol"},{"key":"717_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1099\/mic.0.000496","volume":"163","author":"JC Onishi","year":"2017","unstructured":"Onishi JC, Campbell S, Moreau M, Patel F, Brooks AI, Zhou YX, et al. Bacterial communities in the small intestine respond differently to those in the caecum and colon in mice fed low- and high-fat diets. Microbiology. 2017;163:1189\u201397.","journal-title":"Microbiology"},{"key":"717_CR7","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/ismej.2011.212","volume":"6","author":"EG Zoetendal","year":"2012","unstructured":"Zoetendal EG, Raes J, van den Bogert B, Arumugam M, Booijink CCGM, Troost FJ, et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 2012;6:1415\u201326.","journal-title":"ISME J"},{"key":"717_CR8","doi-asserted-by":"publisher","first-page":"e0137784","DOI":"10.1371\/journal.pone.0137784","volume":"10","author":"E Angelakis","year":"2015","unstructured":"Angelakis E, Armougom F, Carri\u00e8re F, Bachar D, Laugier R, Lagier J-C, et al. A metagenomic investigation of the duodenal microbiota reveals links with obesity. PLoS One. 2015;10:e0137784.","journal-title":"PLoS One"},{"key":"717_CR9","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/ajg.2014.355","volume":"109","author":"P Wacklin","year":"2014","unstructured":"Wacklin P, Laurikka P, Lindfors K, Collin P, Salmi T, L\u00e4hdeaho ML, et al. Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet. Am J Gastroenterol. 2014;109:1933\u201341.","journal-title":"Am J Gastroenterol"},{"key":"717_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1574-695X.2011.00857.x","volume":"63","author":"H Steed","year":"2011","unstructured":"Steed H, Macfarlane GT, Blackett KL, Macfarlane S, Miller MH, Bahrami B, et al. Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota. FEMS Immunol Med Microbiol. 2011;63:346\u201354.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"717_CR11","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1126\/science.1177486","volume":"326","author":"EK Costello","year":"2009","unstructured":"Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326:1694\u20137.","journal-title":"Science"},{"key":"717_CR12","doi-asserted-by":"publisher","first-page":"34055","DOI":"10.1038\/srep34055","volume":"6","author":"Y Chen","year":"2016","unstructured":"\u2022\u2022 Chen Y, Ji F, Guo J, Shi D, Fang D, Li L. Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology. Sci Rep. 2016;6:34055. One of three articles that actually examined the microbiome of cirrhotic patients in the small intestine.","journal-title":"Sci Rep"},{"key":"717_CR13","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/acer.13498","volume":"41","author":"JS Bajaj","year":"2017","unstructured":"\u2022\u2022 Bajaj JS, Kakiyama G, Zhao D, et al. Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver Axis. Alcohol Clin Exp Res. 2017;41:1857\u201365. One of three articles that actually examined the microbiome of cirrhotic patients in the small intestine.","journal-title":"Alcohol Clin Exp Res"},{"key":"717_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/hepr.13207","volume":"48","author":"JP Jacobs","year":"2018","unstructured":"\u2022\u2022 Jacobs JP, Dong TS, Agopian V, et al. Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: the microbiome, microbial markers and liver disease study. Hepatol Res. 2018;48:1108\u201317. One of three articles that actually examined the microbiome of cirrhotic patients in the small intestine.","journal-title":"Hepatol Res"},{"key":"717_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","volume":"8","author":"AM Aly","year":"2016","unstructured":"Aly AM, Adel A, El-Gendy AO, Essam TM, Aziz RK. Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog. 2016;8:42.","journal-title":"Gut Pathog"},{"key":"717_CR16","first-page":"CD003044","volume":"4","author":"B Als-Nielsen","year":"2004","unstructured":"Als-Nielsen B, Gluud LL, Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev. 2004;4:CD003044.","journal-title":"Cochrane Database Syst Rev"},{"key":"717_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362:1071\u201381.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"717_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/apt.13435","volume":"43","author":"JS Bajaj","year":"2016","unstructured":"Bajaj JS. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Aliment Pharmacol Ther. 2016;43(Suppl 1):11\u201326.","journal-title":"Aliment Pharmacol Ther"},{"key":"717_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5114\/aoms.2015.55675","volume":"12","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Feng Y, Cao B, Tian Q. The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis. Arch Med Sci. 2016;12:592\u20136.","journal-title":"Arch Med Sci"},{"key":"717_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2010.05.017","volume":"53","author":"A Gupta","year":"2010","unstructured":"Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol. 2010;53:849\u201355.","journal-title":"J Hepatol"},{"key":"717_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/hep.29369","volume":"66","author":"BH Mullish","year":"2017","unstructured":"\u2022 Mullish BH, McDonald JAK, Thursz MR, Marchesi JR. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology. 2017;66:1354\u20135. The only randomized clinical trial looking at fecal transplant in encephalopathy.","journal-title":"Hepatology"},{"key":"717_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10620-006-3078-2","volume":"51","author":"O Y\u00fcksel","year":"2006","unstructured":"Y\u00fcksel O, K\u00f6kl\u00fc S, Arhan M, Yolcu OF, Ertu\u011frul I, Odemi\u015f B, et al. Effects of esophageal varice eradication on portal hypertensive gastropathy and fundal varices: a retrospective and comparative study. Dig Dis Sci. 2006;51:27\u201330.","journal-title":"Dig Dis Sci"},{"key":"717_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ajg.2009.558","volume":"105","author":"E Scarpellini","year":"2010","unstructured":"Scarpellini E, Valenza V, Gabrielli M, Lauritano EC, Perotti G, Merra G, et al. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol. 2010;105:323\u20137.","journal-title":"Am J Gastroenterol"},{"key":"717_CR24","first-page":"1482","volume":"50","author":"S Pascual","year":"2003","unstructured":"Pascual S, Such J, Esteban A, et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology. 2003;50:1482\u20136.","journal-title":"Hepatogastroenterology"},{"key":"717_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00042737-199907000-00013","volume":"11","author":"B Campillo","year":"1999","unstructured":"Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol. 1999;11:755\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"717_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","volume":"32","author":"A Parlesak","year":"2000","unstructured":"Parlesak A, Sch\u00e4fer C, Sch\u00fctz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000;32:742\u20137.","journal-title":"J Hepatol"},{"key":"717_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2362.2011.02609.x","volume":"42","author":"SF Assimakopoulos","year":"2012","unstructured":"Assimakopoulos SF, Tsamandas AC, Tsiaoussis GI, Karatza E, Triantos C, Vagianos CE, et al. Altered intestinal tight junctions\u2019 expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. Eur J Clin Investig. 2012;42:439\u201346.","journal-title":"Eur J Clin Investig"},{"key":"717_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/MEG.0b013e3282f4710a","volume":"20","author":"MM Aranha","year":"2008","unstructured":"Aranha MM, Cortez-Pinto H, Costa A, da Silva IBM, Camilo ME, de Moura MC, et al. Bile acid levels are increased in the liver of patients with steatohepatitis. Eur J Gastroenterol Hepatol. 2008;20:519\u201325.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"717_CR29","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","volume":"146","author":"B Schnabl","year":"2014","unstructured":"Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513\u201324.","journal-title":"Gastroenterology"},{"key":"717_CR30","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360:eaan5931. \nhttps:\/\/doi.org\/10.1126\/science.aan5931\n\n.","journal-title":"Science."},{"key":"717_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","volume":"67","author":"P Fickert","year":"2017","unstructured":"Fickert P, Wagner M. Biliary bile acids in hepatobiliary injury - what is the link? J Hepatol. 2017;67:619\u201331.","journal-title":"J Hepatol"},{"key":"717_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97\u2013101. \nhttps:\/\/doi.org\/10.1038\/nature12347\n\n.","journal-title":"Nature."},{"key":"717_CR33","first-page":"1739","volume":"25","author":"GE Chung","year":"2011","unstructured":"Chung GE, Yoon J-H, Lee J-H, Kim HY, Myung SJ, Yu SJ, et al. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth. Oncol Rep. 2011;25:1739\u201346.","journal-title":"Oncol Rep"},{"key":"717_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/1751-2980.12191","volume":"15","author":"L Zhu","year":"2014","unstructured":"Zhu L, Shan LJ, Liu YJ, Chen D, Xiao XG, Li Y. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro. J Dig Dis. 2014;15:684\u201393.","journal-title":"J Dig Dis"},{"key":"717_CR35","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.3748\/wjg.v21.i36.10367","volume":"21","author":"H Liu","year":"2015","unstructured":"Liu H, Xu H-W, Zhang Y-Z, Huang Y, Han G-Q, Liang T-J, et al. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice. World J Gastroenterol. 2015;21:10367\u201374.","journal-title":"World J Gastroenterol"},{"key":"717_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","volume":"24","author":"JA Gilbert","year":"2018","unstructured":"Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24:392\u2013400.","journal-title":"Nat Med"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-019-0717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-019-0717-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-019-0717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T23:49:25Z","timestamp":1598053765000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-019-0717-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1007\/s11894-019-0717-2","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]},"assertion":[{"value":"23 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"50"}}